Next earnings date: 4 Nov 2025

Granules India Limited – NSE:GRANULES.NS
Granules India Limited stock price today
Granules India Limited stock price monthly change
Granules India Limited stock price quarterly change
Granules India Limited stock price yearly change
Granules India Limited key metrics
Market Cap | 142.27B |
Enterprise value | 150.94B |
P/E | 29.15 |
EV/Sales | 3.37 |
EV/EBITDA | 15.45 |
Price/Sales | 3.17 |
Price/Book | 4.14 |
PEG ratio | 0.71 |
EPS | 16.72 |
Revenue | 45.06B |
EBITDA | 8.58B |
Income | 4.05B |
Revenue Q/Q | -1.64% |
Revenue Y/Y | -0.12% |
Profit margin | 10.9% |
Oper. margin | 16.98% |
Gross margin | 49.86% |
EBIT margin | 16.98% |
EBITDA margin | 19.05% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGranules India Limited stock price history
Granules India Limited stock forecast
Granules India Limited financial statements
Jun 2023 | 9.85B | 478.95M | 4.86% |
---|---|---|---|
Sep 2023 | 11.89B | 1.02B | 8.58% |
Dec 2023 | 11.55B | 1.25B | 10.87% |
Mar 2024 | 11.75B | 1.29B | 11.03% |
2026 | 58.35B | 7.71B | 13.22% |
---|---|---|---|
2027 | 63.18B | 7.97B | 12.62% |
Analysts Price target
Financials & Ratios estimates
2024-11-06 | 3.85 | 4.01 |
---|
Payout ratio | 0% |
---|
2016 | 0.94% |
---|---|
2017 | 0.73% |
2019 | 1.06% |
2020 | 0.84% |
2022 | 0.49% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 52648490000 | 22.97B | 43.64% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 55209820000 | 22.95B | 41.58% |
Jun 2023 | 984.82M | 0 | 0 |
---|---|---|---|
Sep 2023 | 1.05B | 0 | 0 |
Dec 2023 | 1.04B | 0 | 0 |
Mar 2024 | 0 | 0 | 0 |
Granules India Limited alternative data
Aug 2023 | 3,686 |
---|---|
Sep 2023 | 3,650 |
Oct 2023 | 3,650 |
Nov 2023 | 3,650 |
Dec 2023 | 3,650 |
Jan 2024 | 3,650 |
Feb 2024 | 3,650 |
Mar 2024 | 3,650 |
Apr 2024 | 3,650 |
May 2024 | 3,650 |
Jun 2024 | 3,650 |
Jul 2024 | 3,650 |
Granules India Limited other data
Insider | Compensation |
---|---|
Dr. Krishna Prasad Chigurupati B.Sc. (1954) Chairman & MD | $419,450,000 |
Mr. Harsha Chigurupati (1983) Executive Director | $83,890,000 |
Mr. Sandip Neogi (1967) Chief Financial Officer | $14,110,000 |
-
What's the price of Granules India Limited stock today?
One share of Granules India Limited stock can currently be purchased for approximately $335.95.
-
When is Granules India Limited's next earnings date?
Granules India Limited is estimated to report earnings on Tuesday, 4 Nov 2025.
-
Does Granules India Limited pay dividends?
Yes, Granules India Limited pays dividends and its trailing 12-month yield is 0.26% with 0% payout ratio. The last Granules India Limited stock dividend of $0.25 was paid on 11 Sep 2025.
-
How much money does Granules India Limited make?
Granules India Limited has a market capitalization of 142.27B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 20.91% to 45.06B US dollars. Granules India Limited earned 4.05B US dollars in net income (profit) last year or $4.01 on an earnings per share basis.
-
What is Granules India Limited's stock symbol?
Granules India Limited is traded on the NSE under the ticker symbol "GRANULES.NS".
-
What is Granules India Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Granules India Limited?
Shares of Granules India Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Granules India Limited's key executives?
Granules India Limited's management team includes the following people:
- Dr. Krishna Prasad Chigurupati B.Sc. Chairman & MD(age: 71, pay: $419,450,000)
- Mr. Harsha Chigurupati Executive Director(age: 42, pay: $83,890,000)
- Mr. Sandip Neogi Chief Financial Officer(age: 58, pay: $14,110,000)
-
How many employees does Granules India Limited have?
As Jul 2024, Granules India Limited employs 3,650 workers.
-
When Granules India Limited went public?
Granules India Limited is publicly traded company for more then 20 years since IPO on 20 Jun 2005.
-
What is Granules India Limited's official website?
The official website for Granules India Limited is granulesindia.com.
-
How can i contact Granules India Limited?
Granules India Limited can be reached via phone at +91 40 6904 3500.
Granules India Limited company profile:

Granules India Limited
granulesindia.comNSE
4,057
Drug Manufacturers - Specialty & Generic
Healthcare
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Hyderabad, 500081
:
ISIN: INE101D01020
CUSIP: Y2849A135